We successfully presented our innovation at LSI USA, joining a distinguished community of global leaders and innovators shaping the future of healthcare. Our CEO, Ioanna Zergioti, delivered a compelling presentation, showcasing our transformative technology and vision. We were delighted to connect with investors, strategic partners, and fellow pioneers, and we look forward to building on these valuable interactions. READ MORE

March 20, 2026 PhosPrint successfully completed its technical visits within the NEOLIVER project, achieving the first official installation of its GEN1 laser bioprinter outside the company.The system is now fully operational at DWI – Leibniz Institute for Interactive Materials in Aachen, supporting advanced bioprinting research and collaboration.This milestone strengthens the joint effort toward developing the world’s first autologous bioprinted liver and enhances the reprodu

Our CEO, Ioanna Zergioti, participated in the Women Forum Summit, organized by the SEV Hellenic Federation of Enterprises, alongside distinguished female leaders. The panel focused on the role of women in innovation and technology, offering valuable insights and perspectives. We are proud to contribute to this important dialogue and support the advancement of female leadership in these fields. https://www.linkedin.com/posts/phosprint-p-c_women-forward-summit-powered-by-sev-ac